We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $419B
1-Year Est. Return 43.02%
This Fund
S&P 500
This Quarter Est. Return
+16.98%
1 Year Est. Return
+43.02%
3 Year Est. Return
+139.43%
5 Year Est. Return
+185.66%
10 Year Est. Return
+615.14%
AUM
$295B
AUM Growth
+$35.4B
Cap. Flow
-$1.58B
Cap. Flow %
-0.53%
Top 10 Hldgs %
22.42%
Holding
3,425
New
145
Increased
1,798
Reduced
1,253
Closed
125

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1B
2
AAPL icon
Apple
AAPL
+$797M
3
MRK icon
Merck
MRK
+$316M
4
AMZN icon
Amazon
AMZN
+$308M
5
MDT icon
Medtronic
MDT
+$298M

Sector Composition

Rank Sector Weight
1 Technology 24.73%
2 Healthcare 13.29%
3 Consumer Discretionary 13.23%
4 Financials 12.2%
5 Communication Services 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATI icon
1351
ATI
ATI
$30.9B
$16.7M 0.01%
996,501
-475,970
-32% -$6.05M
PCRX icon
1352
Pacira BioSciences
PCRX
$924M
$16.6M 0.01%
277,394
+39,204
+16% +$2.3M
FOX icon
1353
Fox Class B
FOX
$24.4B
$16.6M 0.01%
573,999
+5,542
+1% +$154K
PATK icon
1354
Patrick Industries
PATK
$2.78B
$16.6M 0.01%
363,804
+212,680
+141% +$9.02M
PNTG icon
1355
Pennant Group
PNTG
$1.35B
$16.6M 0.01%
285,089
-4,687
-2% -$225K
SKY icon
1356
Champion Homes
SKY
$5.23B
$16.5M 0.01%
534,560
+13,666
+3% +$403K
HOUS
1357
DELISTED
Anywhere Real Estate
HOUS
$16.5M 0.01%
1,259,591
+625,253
+99% +$7.46M
BEAM icon
1358
Beam Therapeutics
BEAM
$2.74B
$16.5M 0.01%
202,296
+71,925
+55% +$3.54M
CRSP icon
1359
CRISPR Therapeutics
CRSP
$5.22B
$16.4M 0.01%
107,300
+42,370
+65% +$5.01M
NPO icon
1360
Enpro
NPO
$7.12B
$16.4M 0.01%
216,815
-1,936
-0.9% -$130K
GNMK
1361
DELISTED
GenMark Diagnostics, Inc
GNMK
$16.3M 0.01%
1,116,723
-87,064
-7% -$1.15M
HBI
1362
DELISTED
Hanesbrands
HBI
$16.3M 0.01%
1,116,689
-8,970
-0.8% -$135K
TCBI icon
1363
Texas Capital Bancshares
TCBI
$4.38B
$16.3M 0.01%
273,428
+4,798
+2% +$237K
FELE icon
1364
Franklin Electric
FELE
$4.68B
$16.2M 0.01%
234,732
+25,663
+12% +$1.69M
CNK icon
1365
Cinemark Holdings
CNK
$4.37B
$16.2M 0.01%
931,443
-168
-0% -$2.11K
EVTC icon
1366
Evertec
EVTC
$1.91B
$16.2M 0.01%
412,351
+12,028
+3% +$447K
SLGN icon
1367
Silgan Holdings
SLGN
$4.46B
$16.2M 0.01%
436,973
+10,918
+3% +$393K
AJRD
1368
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$16.2M 0.01%
306,416
-44,840
-13% -$1.8M
ARCB icon
1369
ArcBest
ARCB
$3.28B
$16.2M 0.01%
378,920
-13,206
-3% -$502K
RLI icon
1370
RLI Corp
RLI
$5.87B
$16.1M 0.01%
310,122
+1,260
+0.4% +$60.4K
ORA icon
1371
Ormat Technologies
ORA
$6.98B
$16.1M 0.01%
178,691
+5,592
+3% +$423K
MIDD icon
1372
Middleby
MIDD
$5.29B
$16.1M 0.01%
125,021
+11,548
+10% +$1.39M
HL icon
1373
Hecla Mining
HL
$11.9B
$16.1M 0.01%
2,484,620
-456,743
-16% -$2.43M
PRLB icon
1374
Protolabs
PRLB
$2.21B
$16.1M 0.01%
104,863
-1,254
-1% -$177K
NFG icon
1375
National Fuel Gas
NFG
$7.75B
$16.1M 0.01%
390,576
+205,680
+111% +$8.56M

Similar funds

Nuveen's Q4 2020 Portfolio in Review

As of Q4 2020, Nuveen held 3,425 positions worth $295B, up 14% from $260B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Nuveen's Q4 2020 filing shows 145 new, 1,798 increased, 1,253 reduced and 125 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M. The largest sale was Walt Disney, an estimated $587M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Nuveen's largest Q4 2020 buy was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M.
  • Nuveen added most to Microsoft in Q4 2020, an estimated $1B increase.
  • Nuveen's biggest Q4 2020 reduction was Walt Disney, cutting an estimated $587M.
  • Nuveen fully exited Alcon in Q4 2020, selling an estimated $174M.
  • Nuveen's ten largest holdings make up 22% of its $295B portfolio in Q4 2020.
  • Nuveen opened 145 new positions and closed 125 in Q4 2020.
  • Nuveen's portfolio value rose 14% quarter-over-quarter to $295B.

Based on Nuveen's 13F filing for Q4 2020, filed 16 Feb 2021.